Literature DB >> 7644855

Model inconsistency, illustrated by the Cox proportional hazards model.

I Ford1, J Norrie, S Ahmadi.   

Abstract

We consider problems involving the comparison of two or more treatments where we have the opportunity to adjust for relevant covariates either conditionally in a regression model or implicitly in repeated measures data, for example, in crossover trials. It is seen that for data arising from non-Normal distributions there is the possibility that models adjusting for covariates and those not adjusting for covariates will be inconsistent, that is, at most one of the models can be valid. Alternatively, even if conditional and unconditional models are valid, parameters in each model may have different interpretations. We note that this presents difficulties for the specification and interpretation of the analysis. It is also clear that model validation is critical. Specific attention is paid to survival data analysed by the Cox proportional hazards model.

Mesh:

Year:  1995        PMID: 7644855     DOI: 10.1002/sim.4780140804

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

1.  Choice of parametric accelerated life and proportional hazards models for survival data: asymptotic results.

Authors:  J L Hutton; P F Monaghan
Journal:  Lifetime Data Anal       Date:  2002-12       Impact factor: 1.588

2.  The impact of covariate adjustment at randomization and analysis for binary outcomes: understanding differences between superiority and noninferiority trials.

Authors:  Katherine Nicholas; Sharon D Yeatts; Wenle Zhao; Jody Ciolino; Keith Borg; Valerie Durkalski
Journal:  Stat Med       Date:  2015-02-02       Impact factor: 2.373

3.  Does Cox analysis of a randomized survival study yield a causal treatment effect?

Authors:  Odd O Aalen; Richard J Cook; Kjetil Røysland
Journal:  Lifetime Data Anal       Date:  2015-06-24       Impact factor: 1.588

4.  Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials.

Authors:  Justin J O'Hagan; Miguel A Hernán; Rochelle P Walensky; Marc Lipsitch
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

5.  Meta-analysis of controlled trials of ventilator therapy in acute lung injury and acute respiratory distress syndrome: an alternative perspective.

Authors:  John L Moran; Andrew D Bersten; Patricia J Solomon
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

6.  The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial.

Authors:  Kate Davidson; John Norrie; Peter Tyrer; Andrew Gumley; Philip Tata; Heather Murray; Stephen Palmer
Journal:  J Pers Disord       Date:  2006-10

7.  Covariate-adjusted measures of discrimination for survival data.

Authors:  Ian R White; Eleni Rapsomaniki
Journal:  Biom J       Date:  2014-12-20       Impact factor: 2.207

8.  Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?

Authors:  Theodore Karrison; Masha Kocherginsky
Journal:  Clin Trials       Date:  2018-03-04       Impact factor: 2.486

9.  Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.

Authors:  Dan Jackson; Ian White; J B Kostis; A C Wilson; A R Folsom; K Wu; L Chambless; M Benderly; U Goldbourt; J Willeit; S Kiechl; J W G Yarnell; P M Sweetnam; P C Elwood; M Cushman; B M Psaty; R P Tracy; A Tybjaerg-Hansen; F Haverkate; M P M de Maat; S G Thompson; F G R Fowkes; A J Lee; F B Smith; V Salomaa; K Harald; V Rasi; E Vahtera; P Jousilahti; R D'Agostino; W B Kannel; P W F Wilson; G Tofler; D Levy; R Marchioli; F Valagussa; A Rosengren; L Wilhelmsen; G Lappas; H Eriksson; P Cremer; D Nagel; J D Curb; B Rodriguez; K Yano; J T Salonen; K Nyyssönen; T-P Tuomainen; B Hedblad; G Engström; G Berglund; H Loewel; W Koenig; H W Hense; T W Meade; J A Cooper; B De Stavola; C Knottenbelt; G J Miller; J A Cooper; K A Bauer; R D Rosenberg; S Sato; A Kitamura; Y Naito; H Iso; V Salomaa; K Harald; V Rasi; E Vahtera; P Jousilahti; T Palosuo; P Ducimetiere; P Amouyel; D Arveiler; A E Evans; J Ferrieres; I Juhan-Vague; A Bingham; H Schulte; G Assmann; B Cantin; B Lamarche; J-P Despres; G R Dagenais; H Tunstall-Pedoe; G D O Lowe; M Woodward; Y Ben-Shlomo; G Davey Smith; V Palmieri; J L Yeh; T W Meade; A Rudnicka; P Brennan; C Knottenbelt; J A Cooper; P Ridker; F Rodeghiero; A Tosetto; J Shepherd; G D O Lowe; I Ford; M Robertson; E Brunner; M Shipley; E J M Feskens; E Di Angelantonio; S Kaptoge; S Lewington; G D O Lowe; N Sarwar; S G Thompson; M Walker; S Watson; I R White; A M Wood; J Danesh
Journal:  Stat Med       Date:  2009-04-15       Impact factor: 2.373

10.  Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study.

Authors:  Bradley A Maron; Evan L Brittain; Edward Hess; Stephen W Waldo; Anna E Barón; Shi Huang; Ronald H Goldstein; Tufik Assad; Bradley M Wertheim; George A Alba; Jane A Leopold; Horst Olschewski; Nazzareno Galiè; Gerald Simonneau; Gabor Kovacs; Ryan J Tedford; Marc Humbert; Gaurav Choudhary
Journal:  Lancet Respir Med       Date:  2020-07-27       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.